<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:bqbiol="http://biomodels.net/biology-qualifiers/" xmlns:collex="http://www.collex.org/schema#" xmlns:bqmodel="http://biomodels.net/model-qualifiers/" xmlns:scoro="http://purl.org/spar/scoro/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:biomodel="http://biomodels.net/model-qualifiers/">
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <dc:title>O'Hara-Rudy-CiPA-v1.0 (2017)</dc:title>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <prism:keyword>electrophysiology</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <dc:description>### 
 Model Status



 This CellML version of the model has been converted to Chaste C++ code using PyCML and then checked against the
 FDA's R code which is [available on Github](https://github.com/FDA/CiPA/blob/master/AP_simulation/models/newordherg_qNet.c).
 We curated the model by comparing derivatives through an action potential - these match to an absolute tolerance of
 at worst 1e-10 for every state variable, both in the control situation and after addition of a simulated drug as
 used in the papers below.
 


### 
 Model Structure.



 The model structure follows O'Hara-Rudy (2011), with a new hERG model structure and optimised ion channel
 conductances for studies involving drug action.
 There is a parameter called 'celltype' that specifies whether this is set as a [sub]endocardial cell (celltype 0),
 an
 



 The code is associated with this paper:
 



 KC Chang, S Dutta, GR Mirams, KA Beattie, J Sheng, PN Tran, M Wu, WW Wu, T Colatsky, DG Strauss, Z Li (2017)
 Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in
 Silico Proarrhythmia Risk Assessment Frontiers in Physiology 8:917. [doi:10.3389/fphys.2017.00917](http://dx.doi.org/10.3389/fphys.2017.00917).
 



 The ion current optimisation is described in this paper:
 



 Dutta S, Chang KC, Beattie KA, Sheng J, Tran PN, Wu WW, Wu M, Strauss DG, Colatsky T, Li Z. (2017). Optimization of
 an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment. Frontiers in Physiology. [doi:10.3389/fphys.2017.00616](http://dx.doi.org/10.3389/fphys.2017.00616).
 



 The dynamic model of drug binding to hERG is described in this paper:
 



 Li Z, Dutta S, Sheng J, Tran PN, Wu W, Chang K, Mdluli T, Strauss DG, Colatsky T. (2017) Improving the In Silico
 Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics
 and Multichannel Pharmacology. Circulation: Arrhythmia and Electrophysiology. 2017;10:e004628. [doi:10.1161/CIRCEP.116.004628](http://dx.doi.org/10.1161/CIRCEP.116.004628).</dc:description>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <collex:thumbnail rdf:resource="http://omex-library.org/5a0.omex/journal.pcbi.1002061.g005&amp;size=medium">http://omex-library.org/5a0.omex/journal.pcbi.1002061.g005&amp;size=medium</collex:thumbnail>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <dc:identifier rdf:resource="http://identifiers.org/orcid:0000-0001-5801-5510">http://identifiers.org/orcid:0000-0001-5801-5510</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <rdfs:label>Bilal Shaikh</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <foaf:accountName rdf:resource="https://orcid.org/0000-0001-5801-5510">https://orcid.org/0000-0001-5801-5510</foaf:accountName>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <foaf:name>Bilal Shaikh</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <dc:contributor rdf:resource="local:00001">local:00001</dc:contributor>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <dc:identifier rdf:resource="https://models.physiomeproject.org/e/5a0">https://models.physiomeproject.org/e/5a0</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <rdfs:label>PMR/e: 5a0</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <bqmodel:is rdf:resource="local:00002">local:00002</bqmodel:is>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <dc:identifier rdf:resource="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <rdfs:label>CC BY 3.0</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <dc:license rdf:resource="local:00003">local:00003</dc:license>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <dc:created>2017-12-07T08:39:30</dc:created>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex">
    <dc:modified>2019-08-29T00:32:30</dc:modified>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex/ohara_rudy_cipa_v1_2017.cellml">
    <dc:title>&#13;
    O'Hara-Rudy CiPA v1.0 (2017)&#13;
  </dc:title>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex/ohara_rudy_cipa_v1_2017.cellml">
    <dc:description>### 
 Model Status



 This CellML version of the model has been converted to Chaste C++ code using PyCML and then checked against the
 FDA's R code which is [available on Github](https://github.com/FDA/CiPA/blob/master/AP_simulation/models/newordherg_qNet.c).
 We curated the model by comparing derivatives through an action potential - these match to an absolute tolerance of
 at worst 1e-10 for every state variable, both in the control situation and after addition of a simulated drug as
 used in the papers below.
 


### 
 Model Structure.



 The model structure follows O'Hara-Rudy (2011), with a new hERG model structure and optimised ion channel
 conductances for studies involving drug action.
 There is a parameter called 'celltype' that specifies whether this is set as a [sub]endocardial cell (celltype 0),
 an
 



 The code is associated with this paper:
 



 KC Chang, S Dutta, GR Mirams, KA Beattie, J Sheng, PN Tran, M Wu, WW Wu, T Colatsky, DG Strauss, Z Li (2017)
 Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in
 Silico Proarrhythmia Risk Assessment Frontiers in Physiology 8:917. [doi:10.3389/fphys.2017.00917](http://dx.doi.org/10.3389/fphys.2017.00917).
 



 The ion current optimisation is described in this paper:
 



 Dutta S, Chang KC, Beattie KA, Sheng J, Tran PN, Wu WW, Wu M, Strauss DG, Colatsky T, Li Z. (2017). Optimization of
 an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment. Frontiers in Physiology. [doi:10.3389/fphys.2017.00616](http://dx.doi.org/10.3389/fphys.2017.00616).
 



 The dynamic model of drug binding to hERG is described in this paper:
 



 Li Z, Dutta S, Sheng J, Tran PN, Wu W, Chang K, Mdluli T, Strauss DG, Colatsky T. (2017) Improving the In Silico
 Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics
 and Multichannel Pharmacology. Circulation: Arrhythmia and Electrophysiology. 2017;10:e004628. [doi:10.1161/CIRCEP.116.004628](http://dx.doi.org/10.1161/CIRCEP.116.004628).</dc:description>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex/ohara_rudy_cipa_v1_2017.cellml">
    <collex:thumbnail rdf:resource="http://omex-library.org/5a0.omex/http:/journals.plos.org/ploscompbiol/article/figure/image?id=10.1371/journal.pcbi.1002061.g005&amp;size=medium">http://omex-library.org/5a0.omex/http:/journals.plos.org/ploscompbiol/article/figure/image?id=10.1371/journal.pcbi.1002061.g005&amp;size=medium</collex:thumbnail>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <dc:identifier rdf:resource="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <rdfs:label>CC BY 3.0</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/5a0.omex/ohara_rudy_cipa_v1_2017.cellml">
    <dc:license rdf:resource="local:00004">local:00004</dc:license>
  </rdf:Description>
</rdf:RDF>
